A Phase Ib Study of Alpelisib or Buparlisib Combined with Tamoxifen Plus Goserelin in Premenopausal Women with HR-Positive HER2-Negative Advanced Breast Cancer

Added 242 days ago (19.01.2021)
Authors: Lu, Y.-S., Lee, K. S., Chao, T.-Y., Tseng, L.-M., Chitapanarux, I., Chen, S.-C., Liu, C.-T., Sohn, J., Kim, J. H., Chang, Y.-C., Yang, Y., Shotelersuk, K., Jung, K. H., Valenti, R., Slader, C., Gao, M., Park, Y. H.
Read article